INTRODUCTION
Hepatic amyloidosis is a rare disease that presents as an infiltrative disease involving liver. Amyloidosis is a systemic disease characterized by the extracellular deposition of amyloid protein in many organs. [1] [2] [3] [4] Progressive organ involvement leads to organ malfunction and death usually resulting from renal and/or cardiac involvement. Liver and spleen are major sites of involvement. [1] [2] [3] The wide range of presenting symptoms encountered makes rapid clinical diagnosis difficult. None of the present imaging techniques is capable of specifically demonstrating the presence of amyloid. Even when suspected clinically and radiologically, the diagnosis of amyloidosis depends on a tissue biopsy to confirm the presence of amyloid deposits. 5 To provide more detailed understanding of hepatic amyloidosis, here a case of amyloidosis involving liver is presented with radiological imaging findings including computed tomography (CT).
CASE
A Renal disease was suspected and abdominal ultrasonography was done. Liver showed diffuse coarse echo and hypoechoic pattern with hepatomegaly (Fig. 1A) . Both kidneys showed also diffuse increased cortical echo suggesting renal parenchymal disease (Fig. 1B) .
Dynamic contrast enhanced CT was taken because of abnormal liver echo and size. On arterial phase, there was no enhancing lesion in liver (Fig. 2) . On portal phase, size of liver increased, and especially left lobe showed bulging contoured enlargement and ill-defined hypoattenuation ( She was diagnosed as systemic amyloidosis, and chemotherapy was done. However, hepatic failure with hepatic encephalopathy was aggravated and she got discharged in a moribund state.
DISCUSSION
Amyloid is defined as a substance which: (1) Amyloidosis is usually seen in a systemic form, but 10-20% of cases can be localized. 4 Men are affected more than women, and the mean age of presentation is 55-60 years.
Some causes of secondary amyloidosis are multiple myeloma The ultrasonographic findings of primary hepatic amyloidosis have not been well described. In one reported case, heterogeneous echogenicity was seen in the liver as in the present case.
The frequent findings of conventional precontrast and contrast-enhanced CT are an enlarged liver with heterogeneous decreased attenuation. 1, 6 Calcification may be seen rarely in the hepatic parenchyma. The hepatic parenchyma infiltrated more highly by amyloid may appear as focal hypoattenuating areas on contrast-enhanced CT scans. This finding probably resulted from impairment of blood flow due to vascular involvement and diffuse parenchymal infiltration of amyloid. MR imaging has been used for the evaluation of primary hepatic amyloidosis. One report showed that, although T2
value of the hepatic parenchyma was not changed, T1 value was increased and it could beused to monitoring of chemotherapy. 1 However, the reason for high signal intensity on T1
is not known.
One report showed that the deposition of amyloid in the spleen was identified in about 83% of patients at the time of Mild delayed enhancement was noted in the spleen on delayed phase CT scans. 1, 4 In the spleen, arterial phase CT showed the lack of parenchymal enhancement, and T2-weighted MR imaging showed decreased signal intensity. 
